Eliem Therapeutics, Inc.ELYMNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-17.95%
Near historical average
Average (5y)
-17.39%
Historical baseline
Range
High:-5.48%
Low:-37.57%
CAGR
+26.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -17.95% | -84.1% |
| 2023 | -9.75% | +46.3% |
| 2022 | -18.14% | +51.7% |
| 2021 | -37.57% | -143.4% |
| 2020 | -15.44% | -181.5% |
| 2019 | -5.48% | - |